Connor, Clark & Lunn Investment Management Ltd. Avid Bioservices, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$20 Billion
Q4 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	BUY	$5.01 - $8.16 $153,431 - $249,900	30,625 New	30,625 $235,000
Q2 2019 Aug 07, 2019	SELL	$3.43 - $5.6 $65,979 - $107,721	-19,236 Closed	0 $0
Q1 2019 May 08, 2019	SELL	$3.56 - $4.82 $36,668 - $49,646	-10,300 Reduced 34.87%	19,236 $82,000
Q4 2018 Feb 12, 2019	SELL	$4.04 - $6.75 $67,589 - $112,927	-16,730 Reduced 36.16%	29,536 $121,000
Q3 2018 Nov 13, 2018	BUY	$4.28 - $7.32 $82,372 - $140,880	19,246 Added 71.23%	46,266 $317,000
Q2 2018 Aug 02, 2018	SELL	$3.1 - $3.93 $119,582 - $151,599	-38,575 Reduced 58.81%	27,020 $106,000
Q1 2018 May 14, 2018	BUY	$2.32 - $4.22 $152,180 - $276,810	65,595 New	65,595 $192,000

Others Institutions Holding CDMO

# of Institutions

209

Shares Held

67.1M

Call Options Held

216K

Put Options Held

4.6K

Black Rock Inc. New York, NY

5.11M
Shares

$63.8 Million
0.0% of portfolio
Altra Vue Capital, LLC Bellevue, WA

3.8M
Shares

$47.4 Million
4.5% of portfolio
Vanguard Group Inc Valley Forge, PA

3.77M
Shares

$47.1 Million
0.0% of portfolio
Glazer Capital, LLC New York, NY

3.72M
Shares

$46.4 Million
3.11% of portfolio
Punch & Associates Investment Management, Inc. Edina, MN

2.88M
Shares

$36 Million
2.11% of portfolio

View Full List

About Avid Bioservices, Inc.

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $776M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

More about CDMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account